Bioindustrial Happy Hour

​We are excited to bring investors, corporates, and friends of BII, Forbion, and Juniper together to celebrate the future of synthetic biology and bioindustrial innovations at SynBioBeta. Come join us!

​​__

​Juniper is an early-stage venture capital firm writing the first checks into category-creating companies enabled by breakthroughs in biology, engineering, and computation. Founded by venture-backed entrepreneurs turned investors Jenny Kan and Michael Luciani, the fund is built on Jenny's expertise as Lead Engineer in a Nobel Laureate's synthetic biology lab and Michael's experience building the Climate Capital Syndicate, one of the world's most active climate investment platforms. Learn more: https://www.junipervc.com

​BioInnovation Institute is a leading life science innovation hub dedicated to transforming cutting-edge research into impactful companies that improve human and planetary health. Backed by the Novo Nordisk Foundation, the institute supports entrepreneurs and researchers through funding, world-class laboratories, business development, and access to a strong international network of investors and industry partners.

​Forbion is a leading global venture capital firm with deep roots in Europe and offices in Naarden, the Netherlands, Munich, Germany, and Boston, USA. Forbion invests in innovative biotech companies, managing approximately €5 billion across multiple fund strategies. The Forbion BioEconomy Fund is Forbion’s dedicated investment platform at the intersection of biotechnology and planetary health. The Fund focuses on innovative companies that leverage biotechnology to clean and feed the planet across four sectors: Food, Agriculture, Materials and Environmental Technologies.